Cor Vasa 2021, 63(6):689-696 | DOI: 10.33678/cor.2021.091

Predictive value of Selvester QRS score for severity of coronary artery disease in ST-segment elevation myocardial infarction

Caner Türkoğlua, Ömer Gençb, Taner Şekerc, İbrahin Halil Kurtc
a Department of Cardiology, Malatya Training and Research Hospital, Malatya, Turkey
b Department of Cardiology, Ağri Training and Research Hospital, Ağri, Turkey
c Department of Cardiology, Adana City Training and Research Hospital, Adana, Turkey

Background: QRS score was demonstrated to be a strong predictor of infarct size and poor outcomes in patients with acute ST-segment elevation myocardial infarction (STEMI).

Aim: We aimed to determine the association between the SYNTAX score II (SS-II) and QRS score in patients with STEMI.

Methods: The study included 302 consecutive patients (71.8 % males, mean age 55.1±12.2 years) with STEMI who were treated with primary percutenous coronary intervention (PCI). The patients were divided into two groups according to their SS-II (SS-II ≤32 as low group [n = 241] and SS-II >32 as moderate-high group [n = 61]).

Results: In-patients with moderate-high SS-II score were older. Level of N-terminal pro-B-type natriuretic peptide (NT-proBNP), troponin, wall motion score index and TIMI frame count were significantly higher in the moderate-high SS-II group than in the low SS-II group (p <0.05, for all). Patients with moderate-high SS-II had low ejection fraction (p <0.001). The composite outcome that consists of in-hospital all-cause mortality and major cardiovascular adverse events was significantly higher in the moderate-high SS-II group (p = 0.01). Selvester QRS score was significantly higher in moderate-high SS-II group than in the low SS-II group (p <0.001). QRS score, hypertension, smoking and TIMI frame count were found to be independent predictors of the moderate-high SS-II. The cut-off value of QRS score for predicting SS-II on the basis of receiver operating characteristic (ROC) curve analysis was 9.0, with 50.9% sensitivity and 84.1% specificity (AUC: 0.726, 95% CI: 0.648-0.804, p <0.001).

Conclusion: QRS score is associated with SS-II predicting the severity of coronary artery disease and mortality in patients with STEMI undergoing primary PCI.

Keywords: Hypertension, Selvester QRS score, ST-segment elevation myocardial infarction, SYNTAX score-II, TIMI frame count

Received: June 13, 2021; Revised: June 13, 2021; Accepted: July 26, 2021; Published: December 13, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Türkoğlu C, Genç Ö, Şeker T, Kurt İH. Predictive value of Selvester QRS score for severity of coronary artery disease in ST-segment elevation myocardial infarction. Cor Vasa. 2021;63(6):689-696. doi: 10.33678/cor.2021.091.
Download citation

References

  1. Reindl M, Reinstadler SJ, Feistritzer HJ, et al. Persistent T-wave inversion predicts myocardial damage after ST-elevation myocardial infarction. Int J Cardiol 2017;241:76-82. Go to original source... Go to PubMed...
  2. Selvester RH, Wagner GS, Hindman NB. The Selvester QRS scoring system for estimating myocardial infarct size. The development and application of the system. Arch Intern Med 1985;145:1877-1881. Go to original source...
  3. Bounous EP Jr, Califf RM, Harrell FE Jr, et al. Prognostic value of the simplified Selvester QRS score in patients with coronary artery disease. J Am Coll Cardiol 1988;11:35-41. Go to original source... Go to PubMed...
  4. Palmeri ST, Harrison DG, Cobb FR, et al. QRS Scoring System for Assessing Left Ventricular Function After Myocardial Infarction. N Engl J Med 1982;306:4-9. Go to original source... Go to PubMed...
  5. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-227. Go to PubMed...
  6. Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013;381:639-650. Go to original source... Go to PubMed...
  7. Campos CM, van Klaveren D, Iqbal J, et al. Predictive performance of SYNTAX score II in patients with left main and multivessel coronary artery disease. Circ J 2014;78:1942-1949. Go to original source... Go to PubMed...
  8. Magro M, Nauta S, Simsek C, et al. Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAX score study. Am Heart J 2011;161:771-781. Go to original source... Go to PubMed...
  9. Wang G, Wang C, Zhang Y, et al. Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention. Coron Artery Dis 2016;27:483-489. Go to original source... Go to PubMed...
  10. Tricoci P, Leonardi S, White J, et al. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. J Am Coll Cardiol 2013;62:242-251. Go to original source... Go to PubMed...
  11. Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol 2011;57:2389-2397. Go to original source...
  12. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2018;72:2231-2264. Go to original source... Go to PubMed...
  13. Cockcroft DW, Gault H. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41. Go to original source... Go to PubMed...
  14. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367. Go to original source... Go to PubMed...
  15. Karabağ Y, Çağdaş M, Rencuzogullari I, et al. Comparison of SYNTAX score II efficacy with SYNTAX score and TIMI risk score for predicting in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction. Int J Cardiovasc Imaging 2018;34:1165-1175. Go to PubMed...
  16. Ideker RE, Wagner GS, Ruth WK, et al. Selvester RH. Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. Am J Cardiol 1982;49:1604-1614. Go to original source... Go to PubMed...
  17. Shiomi H, Kosuge M, Morimoto T, et al. CREDO-Kyoto AMI Investigators. QRS score at presentation electrocardiogram is correlated with infarct size and mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Circ J 2017;81:1129-1136. Go to original source... Go to PubMed...
  18. Uyarel H, Cam N, Okmen E, et al. Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Am Heart J 2006;151:e1231-e1237. Go to original source... Go to PubMed...
  19. Tjandrawidjaja MC, Fu Y, Westerhout CM, et al. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol 2010;106:630-634. Go to original source... Go to PubMed...
  20. Petrie CJ, Weir RA, Anwar MS, et al. High sensitivity troponin T in acute medicine; more questions than answers. QJM 2014;107:193-200. Go to original source... Go to PubMed...
  21. Yamazaki K, Iijima R, Nakamura M, Sugi K. High-sensitivity cardiac troponin T level is associated with angiographic complexity of coronary artery disease: a cross-sectional study. Heart Vessels 2016;31:890-896. Go to original source... Go to PubMed...
  22. Eek C, Grenne B, Brunvand H, et al. Strain echocardiography and wall motion score index predicts final infarct size in patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging 2010;3:187-194. Go to original source... Go to PubMed...
  23. Jurado-Roman A, Agudo-Quilez P, Rubio-Alonso B, et al. Superiority of wall motion score index over left ventricle ejection fraction in predicting cardiovascular events after an acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 2019;8:78-85. Go to original source... Go to PubMed...
  24. Çağdaş M, Rencüzoğullari I, Karakoyun S, et al. Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome. Angiology 2019;70:361-368. Go to PubMed...
  25. Zhang C, Jiang L, Xu L, et al. Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease. Eur Heart J 2019;40:3397-3405. Go to original source... Go to PubMed...
  26. Lee JH, Kim JH, Jang SY, et al. A new tool for the risk stratification of patients undergoing primary percutaneous coronary intervention with ST-segment elevation myocardial infarction: Bio-Clinical SYNTAX score. Int J Cardiol 2015;187:193-195. Go to original source... Go to PubMed...
  27. Barbash GI, White HD, Modan M, Van der Werf F. Smoking and acute myocardial infarction. Circulation 1993;87:1427-1428. Go to original source... Go to PubMed...
  28. Albertal M, Cura F, Escudero AG, et al. Mechanism involved in the paradoxical effects of active smoking following primary angioplasty: a subanalysis of the protection of distal embolization in high-risk patients with acute myocardial infarction trial. J Cardiovasc Med 2008;9:810-812. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.